StonvexLoading…
StonvexStonvexStonvexCore line items from QNST's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2024 2024-06-30 | Annual 2023 2023-06-30 | Annual 2022 2022-06-30 | Annual 2021 2021-06-30 |
|---|---|---|---|---|
Revenue | $613.51M | $580.62M | $582.10M | $578.49M |
Operating Income | $-28.07M | $-20.82M | $-4.72M | $13.93M |
Net Income | $-31.33M | $-68.87M | $-5.25M | $23.55M |
EPS (Diluted) | $-0.57 | $-1.28 | $-0.10 | $0.43 |
Total Assets | $368.55M | $337.15M | $419.91M | $449.51M |
Total Liabilities | $151.72M | $107.35M | $133.91M | $154.37M |
Cash & Equivalents | $50.49M | $73.68M | $96.44M | $110.32M |
Free Cash Flow OCF − CapEx | $6.69M | $8.78M | $25.83M | $48.65M |
Shares Outstanding | 55.47M | 54.19M | 53.36M | 53.79M |